Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RT
A completed clinical trial update comparing laboratory blood glucose measurements with the HemoCue Glucose 201 RT in individuals with cystic…
-
FDA approval · 2014-11-10FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
The FDA approved a supplemental application for KALYDECO (ivacaftor) from Vertex Pharmaceuticals Incorporated, resulting in updated labeling…
-
FDA approval · 2014-11-10FDA Approved: CAYSTON — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Cayston (aztreonam) submitted by Gilead Sciences, Inc., marking approval of an updated or expand…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Bronchial Inflammation of Small Airways in Patients With Cystic Fibrosis
This trial update notes the completion of a study evaluating bronchial inflammation of the small airways in patients with cystic fibrosis.
-
FDA approval · 2014-10-24FDA Approved: TOBRAMYCIN — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for tobramycin by Mylan Institutional LLC (ANDA065407). This action approves the generic tobramycin …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency [Phase 3]
A Phase 3 trial of Liprotamase in cystic fibrosis-related exocrine pancreatic insufficiency has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Open-Label Phase III Long-Term Safety Trial of Liprotamase [Phase 3]
The open-label Phase III long-term safety trial of Liprotamase has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Effect of Glycine in Cystic Fibrosis [Phase 2]
Phase 2 trial evaluating glycine for cystic fibrosis; the study was terminated, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients [Phase 1]
A Phase 1 study evaluating BIIL 284 BS in adults and children with cystic fibrosis completed, focusing on safety, tolerability, and pharmaco…
-
CLINICAL_TRIALS research · 2014-10-21Clinical Trial Update: Web-based Delivery of Effective Treatment for Growth in Cystic Fibrosis [NA]
A clinical trial evaluating web-based delivery of an effective treatment for growth in children with cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency [Phase 2]
Oral TheraCLEC is being studied in cystic fibrosis patients with exocrine pancreatic insufficiency in a Phase 2 trial. The study status is l…
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients [Phase 1]
A Phase 1 trial evaluated safety, tolerability, and pharmacokinetics of escalating doses of BIIL 284 BS in adult and pediatric cystic fibros…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis [NA]
A completed clinical trial assessed whether daily iron supplementation improves anemia in individuals with cystic fibrosis, with results pos…
-
FDA approval · 2014-09-30FDA Approved: TOBI PODHALER — Supplemental Application (Viatris Specialty LLC)
FDA approval of a supplemental application for TOBI Podhaler (tobramycin) submitted by Viatris Specialty LLC.
-
FDA approval · 2014-09-26FDA Approved: ZENPEP — Supplemental Application (Aimmune Therapeutics, Inc.)
The FDA approved a supplemental application for Zenpep (pancrelipase) submitted by Aimmune Therapeutics, expanding or updating its labeling/…
-
CLINICAL_TRIALS research · 2014-09-16Clinical Trial Update: LAIV (Flumist®) Administration in CF Patients
This document is a clinical trial update on the administration of Flumist (live attenuated influenza vaccine) in cystic fibrosis patients. T…
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Changes in Adherence After Playing "My Life With CF" Game [NA]
A completed clinical trial assessed changes in treatment adherence after participants played the 'My Life With CF' game.
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Imaging Lung Function Using Oxygen Enhanced MRI [Phase 1]
Phase 1 trial update evaluating oxygen-enhanced MRI to image lung function; the study status is completed and encompasses COPD, asthma, and …
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Deposition of Inhaled Prolastin in Cystic Fibrosis Patients [Phase 2]
Phase 2 results were posted for a study evaluating deposition of inhaled Prolastin in cystic fibrosis patients.
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Supplementation of Oral Reduced Glutathione in Pediatric Cystic Fibrosis Patients [NA]
A completed pediatric cystic fibrosis trial evaluating oral reduced glutathione supplementation; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Volatile Organic Compounds in Cystic Fibrosis
A completed clinical trial evaluating volatile organic compounds in cystic fibrosis patients.
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CF [Phase 1]
Phase 1b safety, tolerability, and pharmacokinetic study of GS-5737 in subjects with cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Phase 1, QT/QTC Interval Study in Healthy Subjects [Phase 1]
Vertex completed a Phase 1 QT/QTc interval safety study in healthy volunteers for a cystic fibrosis drug candidate (Lumacaftor, VX-809).
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Study of the Effect of VX-770 on Hyperpolarized Helium-3 Magnetic Resonance Imaging in Subjects With Cystic Fibrosis and the G551D Mutation [Phase 2]
Phase 2 study assessing the effect of ivacaftor (VX-770) on hyperpolarized Helium-3 MRI markers in cystic fibrosis patients with the G551D C…
-
FDA approval · 2014-07-29FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)
The FDA approved a supplemental application for KALYDECO (ivacaftor) submitted by Vertex Pharmaceuticals Incorporated. The approval covers c…